CNST - Constellation Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5244.39M
Enterprise Value 3163.87M
Trailing P/E N/A
Forward P/E 1-2.79
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.84
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.39

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-13.71%
S&P500 52-Week Change 35.84%
52 Week High 314.04
52 Week Low 34.01
50-Day Moving Average 39.80
200-Day Moving Average 310.13

Share Statistics

Avg Vol (3 month) 367.55k
Avg Vol (10 day) 331.55k
Shares Outstanding 525.81M
Float 9.44M
% Held by Insiders 113.33%
% Held by Institutions 182.39%
Shares Short (Jun 28, 2019) 41.11M
Short Ratio (Jun 28, 2019) 412.48
Short % of Float (Jun 28, 2019) 47.27%
Short % of Shares Outstanding (Jun 28, 2019) 44.32%
Shares Short (prior month May 31, 2019) 4936.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.24%
Return on Equity (ttm)-89.19%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-28.37M
EBITDA -68.58M
Net Income Avi to Common (ttm)-67.25M
Diluted EPS (ttm)-3.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)115.79M
Total Cash Per Share (mrq)4.49
Total Debt (mrq)24.68M
Total Debt/Equity (mrq)28.68
Current Ratio (mrq)6.92
Book Value Per Share (mrq)3.34

Cash Flow Statement

Operating Cash Flow (ttm)-55.38M
Levered Free Cash Flow (ttm)-32.57M